This HTML5 document contains 183 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33422320
rdf:type
wikibase:Item
schema:description
naučni članak מאמר מדעי научная статья articolo scientifico 2015 թուականի Մայիսին հրատարակուած գիտական յօդուած مقالة علمية tudományos cikk vitskapeleg artikkel บทความทางวิทยาศาสตร์ 2015年論文 artigo científico artigo científico (publicado na 2015) wetenschappelijk artikel научни чланак vedecký článok научни чланак scienca artikolo 2015年論文 ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bài báo khoa học 2015年论文 мақолаи илмӣ tieteellinen artikkeli artículo científico publicado en 2015 2015년 논문 2015 թվականի մայիսին հրատարակված գիտական հոդված 2015年論文 مقالهٔ علمی 2015 nî lūn-bûn artikulong pang-agham 2015年论文 mokslinis straipsnis სამეცნიერო სტატია scientific article 2015年论文 article scientifique (publié 2015) επιστημονικό άρθρο artigo científico (publicado na 2015) vědecký článek 2015年论文 teaduslik artikkel wissenschaftlicher Artikel artykuł naukowy научна статия سائنسی مضمون artículu científicu espublizáu en 2015 2015年論文 2015年の論文 мақолаи илмӣ 2015年论文 videnskabelig artikel (udgivet 2015) articol științific article scientific наукова стаття, опублікована в травні 2015 vetenskaplig artikel 2015年论文 article científic bilimsel makale 2015年論文 vitenskapelig artikkel artikull shkencor
p:P577
wds:Q33422320-7A2BAF9A-A15A-45AD-87DE-2A5D04EB588C
wdt:P577
2015-05-25T00:00:00Z
p:P407
wds:Q33422320-09367AC2-AFEC-4240-8665-2DD0B8769594
wdt:P407
wd:Q1860
p:P2860
wds:Q33422320-A3ACD670-C084-45A1-81A9-3D004453A8B0 wds:Q33422320-B806CC8C-4AB1-44ED-81C1-AC9C420CBACB wds:Q33422320-BFE94881-5869-4496-8D54-DE8898CB999E wds:Q33422320-9ED994B3-63A1-4311-BC37-77A9C6E73B08 wds:Q33422320-A0D1F0F5-B4DD-4857-9D33-3EB45AD6B338 wds:Q33422320-DDD3C849-669E-4EFA-9441-2EBE454C1807 wds:Q33422320-E23E2A1A-97A2-4EE4-9FBA-D5279ADDC796 wds:Q33422320-E61B43E1-E6AC-410C-A69E-D32741B15EDC wds:Q33422320-C9068DF6-776B-4C10-AD0C-22EABCD01D83 wds:Q33422320-CDDB8C2F-76BC-46A7-9D8D-E6C43E1C8D26 wds:Q33422320-D156BB8F-31FA-43B2-BBD1-C7DC2EADBCEF wds:Q33422320-D47234DD-8D02-418E-82A9-B0F5C28F3FC2 wds:Q33422320-D73670AA-C61E-499F-BCF7-90F71B1A0CDA wds:Q33422320-0B9A6DD4-0A1A-4850-8813-732483967279 wds:Q33422320-1342D0D7-9CA6-4494-B971-C601C694359B wds:Q33422320-2401C4E9-C6BE-4BB3-9A74-7B51FDC35C74 wds:Q33422320-341648EB-59F6-4F58-8710-F989C5ABC0F3 wds:Q33422320-603330FF-FB29-4FA7-B446-CC38EB7A7A10 wds:Q33422320-63B65256-1FEA-4AC0-8964-E77A6192DADA wds:Q33422320-690F6E33-6657-4BCB-9201-1BA56D604B7F wds:Q33422320-6A088CF3-75A0-482C-A11F-9E47AA15F54C wds:Q33422320-714F2556-2945-4EAE-BAAC-98F8F8E002DF wds:Q33422320-4218FD8A-40A9-4A69-A06B-33A59B482728 wds:Q33422320-4AA258C9-7203-4788-9F79-6892A2CD467D wds:Q33422320-58F83383-32EC-48D3-8F24-822D4E9C81BE wds:Q33422320-5924F60F-38E8-4DF4-BB63-AF977C3BA708 wds:Q33422320-5C9BAE69-33C1-45F6-BC9F-FDC318BE2B9D
wdt:P2860
wd:Q40543180 wd:Q36895477 wd:Q35628327 wd:Q38262473 wd:Q33749658 wd:Q27860890 wd:Q36603677 wd:Q33941370 wd:Q37029162 wd:Q33941411 wd:Q36957261 wd:Q34180677 wd:Q29617571 wd:Q33951212 wd:Q33773306 wd:Q34595904 wd:Q33941346 wd:Q28288381 wd:Q33941357 wd:Q36690893 wd:Q29614601 wd:Q34922227 wd:Q33399980 wd:Q33399977 wd:Q28593921 wd:Q34567629 wd:Q34549410
p:P2093
wds:Q33422320-728D4D78-13EF-4537-99DE-0868E2589ECB wds:Q33422320-741CF7A6-9A89-4D29-8114-6A6DE1BB387C wds:Q33422320-6D44180F-08EE-4527-8831-880450B07EB3 wds:Q33422320-08B29F84-E987-43B8-80D5-C965C0E7C19D wds:Q33422320-EAADB535-D32F-4AB5-AC79-69C01D919915 wds:Q33422320-CE2D6C48-0EC4-458A-8F9E-74DE0CC3A351 wds:Q33422320-CF3A276D-C8DD-4E8F-BA33-8C36EA77083F wds:Q33422320-C2D044BF-58F9-4747-9231-C7B48F8017FD wds:Q33422320-C38BCC07-283C-474F-95EA-56206C792EEA wds:Q33422320-B324B738-7B6D-47EB-B95C-4C8D623BFA16 wds:Q33422320-AFDFFD79-5A13-4914-982D-41BF49D05F8A wds:Q33422320-95867ACC-1037-4207-AFE4-D6F423C94CCD wds:Q33422320-93603061-2D91-4D82-BD23-D3C49FDB613D
wdt:P2093
Michinori Ogura Fumihiko Hayakawa Takeshi Yamauchi Masaaki Motoyama Akiko Kageyama Wataru Munakata Masafumi Taniwaki Takeshi Tsunoda Yasushi Takamatsu Miyuki Yuasa Toshiki Uchida Yasuhito Terui Tomoki Naoe
rdfs:label
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
skos:prefLabel
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
schema:name
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
p:P50
wds:Q33422320-416C0B16-FB5B-402A-9CBF-71D699584106 wds:Q33422320-DDC2E93A-F528-4ADB-AFEB-E8AA69A96FA8 wds:Q33422320-F603F878-6F96-4E5A-A47D-C86387B79F2E
wdt:P50
wd:Q88491888 wd:Q86841621 wd:Q37834872
p:P1476
wds:Q33422320-9F33C36E-90A9-4DA2-9F84-E222E5A8A004
wdt:P1476
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
p:P304
wds:Q33422320-BCD253C0-8AE2-4484-A235-DCC128BD4289
wdt:P304
896-901
p:P31
wds:Q33422320-A064E96C-1B0A-4F17-BC2C-5E1AC99F9E81
wdt:P31
wd:Q13442814
p:P698
wds:Q33422320-4065C5CB-7E6D-4326-878C-3128E1E43FB9
wdtn:P698
n11:25912076
wdt:P698
25912076
p:P1433
wds:Q33422320-5AFD66E2-1009-443A-8426-48DAFC8F558E
wdt:P1433
wd:Q326125
p:P433
wds:Q33422320-4CBA22B1-29B8-452D-AECB-C4D1D26D3CA7
p:P478
wds:Q33422320-9B1EF8F8-E1D1-4643-B741-ECA57115D676
wdt:P433
7
wdt:P478
106
p:P356
wds:Q33422320-29756C16-0023-4495-968E-0844B0BEB1A6
wdtn:P356
n12:CAS.12683
wdt:P356
10.1111/CAS.12683
p:P5875
wds:Q33422320-13BA7D22-8709-471A-818F-335A5678A1CD
wdt:P5875
275414449
p:P932
wds:Q33422320-4ABD2268-B906-4EC9-9C2C-AA96159C88C9
wdt:P932
4520642